Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina Cunningham

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Medicinal Chemistry|March 13, 2009
A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408)Wei Li, Jianchang Li, Yuchuan Wu, et al.
Journal of Medicinal Chemistry|September 4, 2009
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthmaWei Li, Jianchang Li, Yuchuan Wu, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Medicinal Chemistry|March 13, 2009
A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408)Wei Li, Jianchang Li, Yuchuan Wu, et al.
Journal of Medicinal Chemistry|September 4, 2009
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthmaWei Li, Jianchang Li, Yuchuan Wu, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Pageof 2